On May 15th, Hengrui Pharmaceutical announced on the Hong Kong Stock Exchange that it plans to issue 224.5 million H-shares for listing in Hong Kong (depending on the exercise of the offering volume adjustment right and over allotment right), with an issue price not exceeding HKD 44.05 per share and not less than HKD 41.45 per share. It is expected to start trading on the Hong Kong Stock Exchange on May 23rd.
Scan code to share